The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Outcomes at School Age after Postnatal Dexamethasone Therapy for Lung Disease of Prematurity
Open accessAbstract
BACKGROUND: We studied the outcomes at school age in children who had participated in a double-blind, placebo-controlled trial of early postnatal dexamethasone therapy (initiated within 12 hours after birth) for the prevention of chronic lung disease of prematurity. METHODS: Of the 262 children included in the initial study, 159 lived to school age. Of these children, 146 (72 in the dexamethasone group and 74 in the control group) were included in our study. All the infants had had severe respiratory distress syndrome requiring mechanical ventilation shortly after birth. In the dexamethasone group, 0.25 mg of dexamethasone per kilogram of body weight was given intravenously every 12 hours for one week, and then the dose was tapered. We evaluated the children's growth, neurologic and motor function, cognition, and school performance. RESULTS: Children in the dexamethasone group were significantly shorter than the controls (P=0.03 for boys, P=0.01 for girls, and P=0.03 for all children) and had a significantly smaller head circumference (P=0.04). Children in the dexamethasone group had significantly poorer motor skills (P<0.001), motor coordination (P<0.001), and visual-motor integration (P=0.02). As compared with the controls, children in the dexamethasone group also had significantly lower full IQ scores (mean [+/-SD], 78.2+/-15.0 vs. 84.4+/-12.6; P=0.008), verbal IQ scores (84.1+/-13.2 vs. 88.4+/-11.8, P=0.04), and performance IQ scores (76.5+/-14.6 vs. 84.5+/-12.7, P=0.001). The frequency of clinically significant disabilities was higher among children in the dexamethasone group than among controls (28 of 72 [39 percent] vs. 16 of 74 [22 percent], P=0.04). CONCLUSIONS: Early postnatal dexamethasone therapy should not be recommended for the routine prevention or treatment of chronic lung disease, because it leads to substantial adverse effects on neuromotor and cognitive function at school age.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Thinking, Problem Solving, Cognition
D., C. P., & Mayer, R. E. (1984) · The American Journal of Psychology · doi:10.2307/1422612 · Cited by 992
Mental Retardation: Definition, Classification, and Systems of Supports
Luckasson, R. A. (2002) · Cited by 735
Effect of Very Low Birth Weight and Subnormal Head Size on Cognitive Abilities at School Age
Hack, M., Breslau, N., Weissman, B., Aram, D., Klein, N., & Borawski, E. (1991) · New England Journal of Medicine · doi:10.1056/nejm199107253250403 · Cited by 503
A Controlled Trial of Dexamethasone in Preterm Infants at High Risk for Bronchopulmonary Dysplasia
Cummings, J. J., D'Eugenio, D. B., & Gross, S. J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198906083202301 · Cited by 483
Adverse Effects of Early Dexamethasone Treatment in Extremely-Low-Birth-Weight Infants
Stark, A. R., Carlo, W. A., Tyson, J. E., Papile, L.-A., Wright, L. L., Shankaran, S., Donovan, E. F., Oh, W., Bauer, C. R., Saha, S., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101113440203 · Cited by 479
Postnatal Corticosteroids to Treat or Prevent Chronic Lung Disease in Preterm Infants
Committee on Fetus and Newborn (2002) · Pediatrics · doi:10.1542/peds.109.2.330 · Cited by 442
Saigal, S., Szatmari, P., Rosenbaum, P., Campbell, D., & King, S. (1991) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)80043-5 · Cited by 427
Barrington, K. J. (2001) · BMC Pediatrics · doi:10.1186/1471-2431-1-1 · Cited by 421
Early Dexamethasone Therapy in Preterm Infants: A Follow-up Study
Yeh, T. F., Lin, Y. J., Huang, C. C., Chen, Y. J., Lin, C. H., Lin, H. C., Hsieh, W. S., & Lien, Y. J. (1998) · Pediatrics · doi:10.1542/peds.101.5.e7 · Cited by 418
Self-citationControlled Trial of Dexamethasone in Respirator-Dependent Infants with Bronchopulmonary Dysplasia
Avery, G. B., Fletcher, A. B., Kaplan, M., & Brudno, D. S. (1985) · Pediatrics · doi:10.1542/peds.75.1.106 · Cited by 379
Cited by
Socioeconomic status and the brain: mechanistic insights from human and animal research
Hackman, D. A., Farah, M. J., & Meaney, M. J. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2897 · Cited by 1,409
Neonatal MRI to Predict Neurodevelopmental Outcomes in Preterm Infants
Woodward, L. J., Anderson, P. J., Austin, N. C., Howard, K., & Inder, T. E. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053792 · Cited by 1,348
Glucocorticoids, prenatal stress and the programming of disease
Harris, A., & Seckl, J. (2011) · Hormones and Behavior · doi:10.1016/j.yhbeh.2010.06.007 · Cited by 871
Seckl, J. R., & Holmes, M. C. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0515 · Cited by 754
Outcomes for Extremely Premature Infants
Glass, H. C., Costarino, A. T., Stayer, S. A., Brett, C. M., Cladis, F., & Davis, P. J. (2015) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000000705 · Cited by 733
The HELLP syndrome: Clinical issues and management. A Review
Haram, K., Svendsen, E., & Abildgaard, U. (2009) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-9-8 · Cited by 633
Survival and Neurodevelopmental Outcomes among Periviable Infants
Younge, N., Goldstein, R. F., Bann, C. M., Hintz, S. R., Patel, R. M., Smith, P. B., Bell, E. F., Rysavy, M. A., Duncan, A. F., Vohr, B. R., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1605566 · Cited by 538
Cerebellum of the Premature Infant: Rapidly Developing, Vulnerable, Clinically Important
Volpe, J. J. (2009) · Journal of Child Neurology · doi:10.1177/0883073809338067 · Cited by 503
Kinsella, J. P., Greenough, A., & Abman, S. H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68615-7 · Cited by 454
Improved Neurodevelopmental Outcomes for Extremely Low Birth Weight Infants in 2000–2002
Wilson-Costello, D., Friedman, H., Minich, N., Siner, B., Taylor, G., Schluchter, M., & Hack, M. (2007) · Pediatrics · doi:10.1542/peds.2006-1416 · Cited by 394
Grunau, R. E., Holsti, L., Haley, D. W., Oberlander, T., Weinberg, J., Solimano, A., Whitfield, M. F., Fitzgerald, C., & Yu, W. (2005) · Pain · doi:10.1016/j.pain.2004.10.020 · Cited by 393
Vohr, B. R., Wright, L. L., Poole, W. K., McDonald, S. A., & for the NICHD Neonatal Research Network Follow-up Study (2005) · Pediatrics · doi:10.1542/peds.2004-2247 · Cited by 388
Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants
Halliday, H. L., Ehrenkranz, R. A., & Doyle, L. W. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001146.pub2 · Cited by 298
Adults born preterm: A review of general health and system-specific outcomes
Raju, T. N. K., Buist, A. S., Blaisdell, C. J., Moxey-Mims, M., & Saigal, S. (2017) · Acta Paediatrica · doi:10.1111/apa.13880 · Cited by 275
“The factors worsening poor outcomes include the degree of prematurity (13,36), exposure to postnatal dexamethasone or other postnatal steroids (25) and intrauterine growth restriction (22).”
BackgroundDoyle, L. W., Cheong, J. L., Ehrenkranz, R. A., & Halliday, H. L. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001146.pub5 · Cited by 260
Quality of Life in Patients after Long-Term Biochemical Cure of Cushing’s Disease
van Aken, M. O., Pereira, A. M., Biermasz, N. R., van Thiel, S. W., Hoftijzer, H. C., Smit, J. W. A., Roelfsema, F., Lamberts, S. W. J., & Romijn, J. A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1375 · Cited by 253
Glucocorticoids, developmental ‘programming’ and the risk of affective dysfunction
Seckl, J. R. (2007) · Progress in Brain Research · doi:10.1016/s0079-6123(07)67002-2 · Cited by 245
Glucocorticoid “Programming” and PTSD Risk
SECKL, J. R., & MEANEY, M. J. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1364.027 · Cited by 234
Chew, L.-J., Fusar-Poli, P., & Schmitz, T. (2013) · Developmental Neuroscience · doi:10.1159/000346157 · Cited by 154
Samarasinghe, R. A., Di Maio, R., Volonte, D., Galbiati, F., Lewis, M., Romero, G., & DeFranco, D. B. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102821108 · Cited by 120
Kunin‐Batson, A., Kadan‐Lottick, N., & Neglia, J. P. (2014) · Psycho-Oncology · doi:10.1002/pon.3470 · Cited by 112
Bochenek, G. (2004) · Thorax · doi:10.1136/thx.2003.013573 · Cited by 106
Blood pressure disorders in the neonate: Hypotension and hypertension
Fanaroff, J. M., & Fanaroff, A. A. (2006) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2006.01.002 · Cited by 84
Nanthakumar, N. N., Young, C., Ko, J. S., Meng, D., Chen, J., Buie, T., & Walker, W. A. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00169.2004 · Cited by 79
Suominen, P. K., Dickerson, H. A., Moffett, B. S., Ranta, S. O., Mott, A. R., Price, J. F., Heinle, J. S., McKenzie, E. D., Fraser, C. D., & Chang, A. C. (2005) · Pediatric Critical Care Medicine · doi:10.1097/01.pcc.0000185487.69215.29 · Cited by 67
Witchel, S. F., & DeFranco, D. B. (2006) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0323 · Cited by 58
Cooperativity and complementarity: Synergies in non-classical and classical glucocorticoid signaling
Samarasinghe, R. A., Witchell, S. F., & DeFranco, D. B. (2012) · Cell Cycle · doi:10.4161/cc.21018 · Cited by 54
Hirvikoski, T., Lindholm, T., Lajic, S., & Nordenström, A. (2011) · Acta Paediatrica · doi:10.1111/j.1651-2227.2011.02260.x · Cited by 49
“In addition, premature infants treated with DEX during 1 week postnatally were shown to have lower intellectual performance at school age as compared to controls (6) Long-term effects of DEX treatment for CAH are now beginning to be addressed as the oldest children treated are reaching early adulthood.”
Background
Metadata
- Authors
- Yeh, T. F., Lin, Y. J., Lin, H. C., Huang, C. C., Hsieh, W. S., Lin, C. H., & Tsai, C. H.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-03-25
- Volume
- 350
- Issue
- 13
- Pages
- 1304-1313
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2014273178
- Cited by
- 596
- References
- 26
- FWCI
- 42.42
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.